3930 Washington Street Kansas City, MO 64111

  • Research Site Introduction:


    Our Mission at Clinical Research Consultants is to provide the highest quality patient care while meeting or exceeding Good Clinical Practice guidelines and following Federal Regulations in all aspects of Phase I, Phase II, Phase III and Phase IV pharmaceutical trials. The research is completed by experienced investigators and highly professional medical staff.


    Meet Ahmed M. Awad, DO, FASN - CEO, Principal Investigator: 

    Dr. Ahmed Awad is a Board Certified Nephrologist and Internal Medicine doctor, practicing medicine for over 15 years.

    Dr. Awad earned his osteopathic medicine degree in 1994 from the Kansas City University of Medicine & Biosciences. He went on to complete an Internal Medicine residency and Nephrology fellowship at the University of Missouri-Kansas City School of Medicine.

    Following the completion of his doctoral studies, Dr. Awad joined Kansas City Kidney Consultants. He has a special interest in the epidemiologic and demographic reasons for the progression of kidney disease and its effect on the cardiac disease.

    Outside of practicing medicine, Dr. Awad is an Assistant Professor of Medicine at the University of Missouri-Kansas City, private consulting nephrologist at St. Luke's Hospital in Kansas City, President of the National Kidney Foundation of Kansas and Western Missouri, and Chair of the Early Intervention Program at the National Kidney Foundation. Dr. Awad has written guidelines for the primary care physician on early detection and diagnosis of kidney disease, which received the KIDOQI Seal of Approval. He was also appointed by Missouri Governor, for the Chronic Kidney Disease Task Force in November of 2007.

    He has also co-authored several medical publications and directed several clinical research trials.

  • Research Site Description:


    Clinical Research Studies open for enrollment now (Latest Dec 2022-2023):

    • Atherosclerotic Cardiovascular Disease (ASCVD) with Chronic Kidney Disease, and Inflammation
    • Chronic Kidney Disease (CKD)
    • Diabetic Kidney Disease
    • Focal Segmental Glomerulosclerosis (FSGS)
    • Hyperkalemia
    • Hypertension & CKD 3 – CKD 4
    • Immunoglobulin A (IgA)
    • Neuropathy Lupus Nephritis
    • Primary Membranous Neuropathy
    • Proteinuria

  • Patient Demographics:

    Clinical Research Consultants is actively recruiting for eligible patients 18+ of age in the Kansas City, KS and Kansas City, MO, United States.

  • Additional Information:

    Recruiting Eligible Patients in the Kansas City, KS and Kansas City, Missouri area.

  • Contact Information:


    If you are interested in learning more about what clinical study is right for you, or would like to participate in a study, or to receive additional study information, please contact our office today at (816) 756-1222.

    Clinical Research Consultants:

    3930 Washington Street

    Kansas City, MO 64111